Clinical trial / 2008
In type 2 diabetics, 12 weeks of vinegar ingestion significantly reduced urinary pH compared to pickles or vinegar pills, with no significant adverse event differences.
Twenty-seven participants with type 2 diabetes were randomized to receive commercial vinegar pills (30 mg acetic acid daily), pickles (approximately 1,400 mg acetic acid daily), or vinegar (2,800 mg acetic acid daily) for 12 weeks. Adverse event reporting did not differ significantly between groups, though 50-56% of pickle and vinegar participants reported at least one adverse event at week 6 versus 11% in the reference group (P = .110). At week 12, urinary pH was significantly reduced in the vinegar group (-9% vs. +3% for pickles and +2% for reference, P = .023). Aspartate aminotransferase showed a tendency to increase in the vinegar group at week 6 (+17% vs. +8% for pickles and -8% for reference, P = .090).
- Study type
- Randomized controlled trial
- Who was studied
- 27 individuals with type 2 diabetes
- What was measured
- Safety, tolerance, adverse events, urinary pH, and fasting blood/urine measures
THE PAPER
A preliminary evaluation of the safety and tolerance of medicinally ingested vinegar in individuals with type 2 diabetes.
Johnston CS, White AM, Kent SM. J Med Food, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.